{"product_id":"memorial-sloan-kettering-cancer-center-9th-annual-advances-in-colorectal-oncology-2025","title":"Memorial Sloan Kettering Cancer Center 9th Annual Advances in Colorectal Oncology 2025","description":"\u003cdiv\u003e\n\u003cdiv class=\"prod-edition\"\u003e\n\u003cdiv class=\"ma-product\"\u003e\u003csection\u003e\n\u003ch1 class=\"product_title entry-title\"\u003eMemorial Sloan Kettering Cancer Center 9th Annual Advances in Colorectal Oncology 2025\u003c\/h1\u003e\n\u003cstrong\u003e+ Include: 21 videos + 21 pdf, size: 8.04 GB\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e+ Target Audience: medical oncologists, radiation oncologists, interventional radiologists, colorectal\/hepatopancreatobiliary\/oncologic surgeons, gastroenterologists, pathologists\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e+ Information:\u003c\/strong\u003e\n\u003cbr\u003e\u003cdiv class=\"activitysectionbold\"\u003eDate \u0026amp; Location Thursday, November 6, 2025, 8:00 AM – Friday, November 7, 2025, 5:30 PM, Zuckerman Research Center, 417 East 68th Street, New York, NY\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cem\u003eSpecialties\u003c\/em\u003e – Clinical Pathology, Colorectal Surgery, Gastroenterology, Gastrointestinal Oncology, General Surgery, Interventional Radiology, Medical Oncology, Pathology, Radiation Oncology, Solid Tumor Oncology, Surgical Oncology, Surgical Pathology\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv class=\"activitysectionbold\"\u003e\u003cstrong\u003eOverview\u003c\/strong\u003e\u003c\/div\u003e\n\u003cbr\u003eThis two-day live symposium at Memorial Sloan Kettering Cancer Center will focus on the surgical and multidisciplinary management of colorectal cancer. National and international leaders in surgery, medical oncology, and radiation oncology will address current controversies and highlight emerging approaches in the treatment of both localized and metastatic disease.\u003cbr\u003e\u003cbr\u003eHighlights of this year’s program include:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eLive surgery presentations\u003c\/strong\u003e streamed directly from MSK’s operating rooms\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFocused sessions exploring current controversies\u003c\/strong\u003e in the medical and surgical management of rectal cancer, with a focus on TNT and Watch-and-Wait approaches\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCutting edge updates in the treatment of colorectal malignancies\u003c\/strong\u003e, including advances in KRAS and BRAF targeted therapies\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eReviews of recent clinical trials\u003c\/strong\u003e in colon, rectal, and anal cancers\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eInteractive multidisciplinary tumor boards\u003c\/strong\u003e featuring complex case discussions\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eNetworking opportunities\u003c\/strong\u003e to connect with leading experts and peers\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cbr\u003eThis comprehensive program is designed to equip participants with the latest evidence-based strategies and multidisciplinary perspectives that are shaping the future of colorectal cancer care—ultimately advancing clinical practice and improving patient outcomes.\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eTarget Audience: \u003c\/strong\u003eThis symposium is intended for medical oncologists, radiation oncologists, interventional radiologists, colorectal\/hepatopancreatobiliary\/oncologic surgeons, gastroenterologists, pathologists, and other oncology care team members interested in rectal cancer.\u003cstrong\u003e A virtual attendance option is available\u003c\/strong\u003e for those unable to join us in New York City.\u003cbr\u003e\u003cbr\u003e\u003cb\u003ePost-Symposium Resources:\u003c\/b\u003e\u003cspan class=\"Apple-converted-space\"\u003e \u003c\/span\u003eAll registered participants will also receive access to an online syllabus following the symposium, which will include presentation recordings and faculty slide decks in PDF format.\u003cbr\u003e\u003cdiv class=\"activitysectionbold\"\u003e\u003cstrong\u003eObjectives\u003c\/strong\u003e\u003c\/div\u003e\n\u003cdiv\u003eAt the conclusion of this symposium, attendees will be able to:\u003c\/div\u003e\n\u003col\u003e\n\u003cli\u003eDescribe the requirements for a successful, multidisciplinary colorectal cancer program\u003c\/li\u003e\n\u003cli\u003eDiscuss technical options for the surgical management of distal rectal cancer\u003c\/li\u003e\n\u003cli\u003eIdentify appropriate candidates for Watch and Wait and adjuncts to optimize organ preservation\u003c\/li\u003e\n\u003cli\u003eDiscuss evidence-based practice recommendation for the management of metastatic colorectal cancer\u003c\/li\u003e\n\u003cli\u003eReview advancements in immunotherapy and alternative strategies for managing colorectal cancer\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003e+ Topics:\u003c\/strong\u003e\n\u003cbr\u003e\u003cdiv class=\"6u 12u(small)\"\u003e\n\u003ch3 class=\"boxAgendaTitle\"\u003eThursday, November 6, 2025\u003c\/h3\u003e\n\u003cdiv class=\"boxAgendaTitle agendaBlue\"\u003e\n\u003cdiv\u003eColorectal General Session\u003c\/div\u003e\n\u003cbr\u003eOnly PDFs and videos consented to by faculty are available below. Multidisciplinary Tumor Boards will not be posted on the online syllabus.\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\u003cstrong\u003eIs There Still a Role forLaparoscopic TaTME?\u003c\/strong\u003e\u003c\/div\u003e\n\u003cul\u003e\n\u003cli class=\"10u\"\u003e1:30PM – 1:45PM\u003c\/li\u003e\n\u003cli class=\"10u\"\u003ePatricia Sylla, MD, FACS, FASCRS\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\u003cstrong\u003eWhen There is No Room for Stapling: Coloanal Anastomois or APR?\u003c\/strong\u003e\u003c\/div\u003e\n\u003cul\u003e\n\u003cli class=\"10u\"\u003e1:45PM – 2:00PM\u003c\/li\u003e\n\u003cli class=\"10u\"\u003eMartin R. Weiser, MD\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\u003cstrong\u003eManaging the Perineal Wound After APR: Primary Closure, Mesh, or Flaps?\u003c\/strong\u003e\u003c\/div\u003e\n\u003cul\u003e\n\u003cli class=\"10u\"\u003e2:00PM – 2:15PM\u003c\/li\u003e\n\u003cli class=\"10u\"\u003eEmmanouil Pappou, MD,PhD\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\u003cstrong\u003eSalvage Local Excision for Incomplete Responders: Are We Pushing Organ Preservation Too Far?\u003c\/strong\u003e\u003c\/div\u003e\n\u003cul\u003e\n\u003cli\u003e2:15PM – 2:30PM\u003c\/li\u003e\n\u003cli\u003eGeerard Beets, MD, PhD, Professor of Surgical Oncology\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\u003cstrong\u003eBrachytherapy for Incomplete Response After Neoadjuvant Therapy: When and How?\u003c\/strong\u003e\u003c\/div\u003e\n\u003cul\u003e\n\u003cli class=\"10u\"\u003e2:30PM – 2:45PM\u003c\/li\u003e\n\u003cli class=\"10u\"\u003eAbraham J. J Wu, MD\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\u003cstrong\u003eControversies in the Surgical Management of Distal Rectal Cancer in the Era of TNT and Watch-and-Wait – Q\u0026amp;A and Panel Discussion\u003c\/strong\u003e\u003c\/div\u003e\n\u003cul\u003e\n\u003cli class=\"10u\"\u003e2:45PM – 3:15PM\u003c\/li\u003e\n\u003cli class=\"10u\"\u003eGeorgios Karagkounis, MD (Moderator)\u003c\/li\u003e\n\u003cli class=\"10u\"\u003eIris H. Wei, MD (Moderator)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"6u 12u(small)\"\u003e\n\u003ch3 class=\"boxAgendaTitle\"\u003eFriday, November 7, 2025\u003c\/h3\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cstrong\u003eThe Harbinger’s Dilemma: ctDNA in Colorectal Cancer\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003e8:05AM – 9:00AM\u003c\/li\u003e\n\u003cli\u003eScott Kopetz, MD, PhD\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cstrong\u003eManagement Options for Intermediate Risk Mid Rectal Cancer\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003e9:00AM – 9:25AM\u003c\/li\u003e\n\u003cli\u003eLeonard B Saltz, MD\u003c\/li\u003e\n\u003cli\u003eJurriaan Tuynman, MD, PhD\u003c\/li\u003e\n\u003cli\u003eNeoadjuvant Therapy for Everyone — Leonard Saltz, MDNeoadjuvant Therapy is Rarely Neccesary — Jurriaan Tuynman, MD, PhD\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\u003cstrong\u003eNear Complete Response After Neoadjuvant Therapy for Locally Advanced Rectal Cancer\u003c\/strong\u003e\u003c\/div\u003e\n\u003cul\u003e\n\u003cli class=\"10u\"\u003e9:25AM – 9:50AM\u003c\/li\u003e\n\u003cli class=\"10u\"\u003eMaria Widmar, MD, Assistant Attending\u003c\/li\u003e\n\u003cli class=\"10u\"\u003eIris H. Wei, MD\u003c\/li\u003e\n\u003cli class=\"10u\"\u003eSurgery Now — Iris H. Wei, MD, FACSNo Need to Rush to the OR — Maria Widmar, MD, MPH \u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\u003cstrong\u003eNeoadjuvant Chemotherapy for pMMR Locally Advanced Colon Cancer\u003c\/strong\u003e\u003c\/div\u003e\n\u003cul\u003e\n\u003cli class=\"10u\"\u003e9:50AM – 10:15AM\u003c\/li\u003e\n\u003cli class=\"10u\"\u003eAlessandro Fichera, MD, FACS, FASCRS, FISS, FCCF\u003c\/li\u003e\n\u003cli class=\"10u\"\u003eAnwaar Saeed, MD\u003c\/li\u003e\n\u003cli class=\"10u\"\u003ePro — Anwaar Saeed, MDCon — Alessandro Fichera, MD \u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\u003cstrong\u003eNew Immuno-Oncology Strategies in Colorectal Cancer\u003c\/strong\u003e\u003c\/div\u003e\n\u003cul\u003e\n\u003cli class=\"10u\"\u003e10:15AM – 10:40AM\u003c\/li\u003e\n\u003cli class=\"10u\"\u003eVinod Balachandran, MD, Associate Member\u003c\/li\u003e\n\u003cli class=\"10u\"\u003eKai-Keen Shiu, MBBS, PhD, FRCP\u003c\/li\u003e\n\u003cli class=\"10u\"\u003eImmune Checkpoint Blockade in pMMR Colon and Rectal Cancer — Kai-Keen Shiu, PhD, FRCPmRNA Vaccines — Vinod P. Balachandran, MD (Please note, slides are not\u003c\/li\u003e\n\u003cli class=\"10u\"\u003eavailable for this presentation) \u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\u003cstrong\u003eStructured Exercise to Reduce Colorectal Cancer Recurrence\u003c\/strong\u003e\u003c\/div\u003e\n\u003cul\u003e\n\u003cli class=\"10u\"\u003e11:00AM – 11:15AM\u003c\/li\u003e\n\u003cli class=\"10u\"\u003eJessica Scott, PhD\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\u003cstrong\u003ectDNA Testing to Guide Colorectal Cancer Management: Is The Time Now?\u003c\/strong\u003e\u003c\/div\u003e\n\u003cul\u003e\n\u003cli class=\"10u\"\u003e11:15AM – 11:30AM\u003c\/li\u003e\n\u003cli class=\"10u\"\u003eLuis Diaz Jr., MD\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\u003cstrong\u003eColorectal Cancer Plasticity and Evolution\u003c\/strong\u003e\u003c\/div\u003e\n\u003cul\u003e\n\u003cli class=\"10u\"\u003e11:30AM – 11:45AM\u003c\/li\u003e\n\u003cli class=\"10u\"\u003eKaruna Ganesh, MD\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\u003cstrong\u003eGenome Driven Treatment of Metastatic Colorectal Cancer\u003c\/strong\u003e\u003c\/div\u003e\n\u003cul\u003e\n\u003cli class=\"10u\"\u003e11:45AM – 12:00PM\u003c\/li\u003e\n\u003cli class=\"10u\"\u003eRona Yaeger, MD\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\u003cstrong\u003eNew Therapies for Refractory dMMR Metastatic Colorectal Cancer\u003c\/strong\u003e\u003c\/div\u003e\n\u003cul\u003e\n\u003cli class=\"10u\"\u003e12:00PM – 12:15PM\u003c\/li\u003e\n\u003cli class=\"10u\"\u003eMichael Foote, MD\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\u003cstrong\u003eAspirin for Chemoprevention in Early Stage Colorectal Cancer\u003c\/strong\u003e\u003c\/div\u003e\n\u003cul\u003e\n\u003cli\u003e12:15PM – 12:30PM\u003c\/li\u003e\n\u003cli\u003eAndrew T Chan, MD, MPH\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\u003cstrong\u003eThe REAL Trial\u003c\/strong\u003e\u003c\/div\u003e\n\u003cul\u003e\n\u003cli class=\"10u\"\u003e1:30PM – 2:00PM\u003c\/li\u003e\n\u003cli class=\"10u\"\u003eGeerard Beets, MD, PhD, Professor of Surgical Oncology (Panelist)\u003c\/li\u003e\n\u003cli class=\"10u\"\u003eQingyang Feng, MD, Associate Professor (Presenter)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\u003cstrong\u003eTESAR Trial\u003c\/strong\u003e\u003c\/div\u003e\n\u003cul\u003e\n\u003cli class=\"10u\"\u003e2:00PM – 2:30PM\u003c\/li\u003e\n\u003cli class=\"10u\"\u003eMartin R. Weiser, MD (Panelist)\u003c\/li\u003e\n\u003cli class=\"10u\"\u003eJurriaan Tuynman, MD, PhD (Presenter)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\u003cstrong\u003eStellar 303\u003c\/strong\u003e\u003c\/div\u003e\n\u003cul\u003e\n\u003cli class=\"10u\"\u003e2:30PM – 3:00PM\u003c\/li\u003e\n\u003cli class=\"10u\"\u003eNeil H. H Segal, MD, PhD (Panelist)\u003c\/li\u003e\n\u003cli class=\"10u\"\u003eAnwaar Saeed, MD (Presenter)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cstrong\u003ePod1um 303\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003e3:00PM – 3:30PM\u003c\/li\u003e\n\u003cli\u003eMaliha Nusrat, MBBS (Panelist)\u003c\/li\u003e\n\u003cli\u003eSheela Rao, MBBS, MD, FRCP, Consultant Medical Oncologist, Reader in Gastrointestinal Cancers (Presenter)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"related products\"\u003e\u003c\/section\u003e","brand":"Medical Education Hub","offers":[{"title":"Default Title","offer_id":54662753288521,"sku":"MED-AMB05774","price":50.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1019\/0382\/7273\/files\/Memorial-Sloan-Kettering-Cancer-Center-9th-Annual-Advances-in-Colorectal-Oncology-2025.jpg?v=1781874129","url":"https:\/\/medicalducation.com\/products\/memorial-sloan-kettering-cancer-center-9th-annual-advances-in-colorectal-oncology-2025","provider":"Medical Education Hub","version":"1.0","type":"link"}